VTAK insider transaction filings
Catheter Precision, Inc. — 19 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-03-30. Screen VTAK transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-30 | 4 | Arno Andrew — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-03-30 | 4 | Caruso James Joseph — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-03-30 | 4 | ANDERSON PHILIP J — Chief Financial Officer | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-03-30 | 4 | JENKINS DAVID A — Chairman of the Board and CEO, Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-03-30 | 4 | COLOMBATTO MARTIN J — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | JENKINS DAVID A — Chairman of the Board and CEO, Director | Other (J): 2,491.29 (derivative) · Other (J): 6,998.19 (derivative) | EDGAR |
| 2026-01-20 | 4 | JENKINS DAVID A — Chairman of the Board and CEO | Other (J): 170,000 (derivative) @ $1.56 · Other (J): 170,000 (derivative) @ $1.56 | EDGAR |
| 2025-12-08 | 4 | Caruso James Joseph — Director | Conversion (C): 41 @ $0 · Conversion (C): 7.93 (derivative) @ $0 | EDGAR |
| 2025-12-08 | 4 | JENKINS DAVID A — Chairman of the Board and CEO | Conversion (C): 12,064 @ $0 · Conversion (C): 30,844 @ $0 · Conversion (C): 98 @ $0 · Conversion (C): 2,292.34 (derivative) @ $0 · Conversion (C): 5,860.54 (derivative) @ $0 · Conversion (C): 18.69 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | Arno Andrew — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | Caruso James Joseph — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | JENKINS DAVID A — Exec. Chairman of the Board, Director | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | COLOMBATTO MARTIN J — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | ANDERSON PHILIP J — Chief Financial Officer | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | Jacques Marie-Claude — Chief Commercial Officer | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | Arno Andrew — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | Caruso James Joseph — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | JENKINS DAVID A — Chairman of the Board and CEO | Grant/award (A): 450,000 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | COLOMBATTO MARTIN J — Director | Sale (S): 3 @ $0.40 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Catheter Precision, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-31 | 8-K | 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-29 | 8-K/A | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-15 | 8-K | 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-18 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-23 | 8-K | 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-15 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-03-31 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=VTAK returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →